Junshi Biosciences has announced that the first healthy volunteer has been dosed in a Phase I clinical study of JS016 in China. JS016 is …
Drugmaker Eli Lilly & Co (LLY) said that the U.S.
Eli Lilly (LLY) has today announced patients have been dosed in the world’s first study of a potential antibody treatment designed to fight …
Junshi Biosciences Co Ltd said on Tuesday that it is gearing up to initiate clinical trials to test its experimental COVID-19 antibodies together …
Drugmaker Eli Lilly & Co (LLY) said the U.S.
Drugmaker Eli Lilly & Co (LLY) said on Tuesday it has reduced the out-of-pocket cost for insulin to $35 per month to help …
Incyte Corporation (NASDAQ:INCY) and Eli Lilly and Co (NYSE:LLY) announced that the U.S.
Incyte Corporation (NASDAQ:INCY) and Eli Lilly and Co (NYSE:LLY) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
J.P.
This morning Eli Lilly and Co (NYSE:LLY) announced that its Phase 3 EXPEDITION-3 trial evaluating solanezumab in Alzheimer’s failed. LLY noted that while …
